• Latest Posts

ADC Therapeutics pauses clinical trial following patient deaths

ADC Therapeutics announces series of financial moves including $175M loan from Owl Rock

Kelun-Biotech announces joint license agreement with MSD for drug targeting solid tumors

ADC Approval Buoys Spirits in Cancer Treatment Space

A Year to Remember: The Biggest European Biotech News in 2020

Update: ADC Therapeutics’ IPO Hits Above Target with €215M


ADC Therapeutics Cancels Nasdaq IPO Amidst Market Growth Fears

ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment

Update: Swiss Biotech’s Series E Expanded to €271M to Commercialize Antibody-Guided Cancer Chemotherapy

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients